Radiosynthesis modules are automated equipment used for radio pharmaceuticals synthesis and the molecular labelling. It is used for the formulation and production of radiotracers. Radioactive tracers are chemical compound in which atoms are replaced by radioisotope, radioactive decay mechanism is used to trace the path that is followed by radioisotope to form product. Mainly radioisotopes are manufactured in radiopharmaceutical units and laboratories. The half-life of radiotracers are limited, thus decreasing the performance in diagnostics and therapeutics. The scope of customization of production of radiotracer is decreased with the increase in time interval for the radiotracer to reach the end user. Radiosynthesis modules are easy to use and set and offers the scope for customization of the radiotracers. The product obtained from the automated radiosynthesis module can be used for both research and in the field of therapeutic nuclear medicine.
Gain complete access to the report @ https://www.futuremarketinsights.com/reports/automated-radiosynthesis-modules-market
Nuclear medicine therapy is performed differently for different indications. While treatment of thyroid cancer or overactive thyroid gland, nuclear medicine is swallowed in a capsule or liquid form. Patients are usually treated as outpatients where single dose is needed in most of the cases. During treatment of joint pain (Arthritis), nuclear medicine is injected into joint fluid under local anaesthetic post which the joint is immobilized with the help of bandage or light splint. Bones affected due to spreading of pain caused by cancer is treated by injecting radiopharmaceutical in a vein in the arms. Automated radiosynthesis module is used during Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) imaging. It is the most common imaging techniques used in nuclear medicine.
Automated Radiosynthesis Modules Market: Drivers & Restraints
Automated Radiosynthesis Module market growth is expected to fuel by factors such as research and development on radiopharmaceuticals, increasing incidence of cancer cases, and rising awareness about SPECT, PET and nuclear medicine. Other factors such as use of PET probe for accurate diagnosis of Alzheimer’s disease, Parkinson’s disease, arthritis and hyperthyroidism, detection of cancer, monitoring the response to cancer treatment and to detect metastases and others are projected to favor the Automated Radiosynthesis Module market over the forecast period.
Some factors such as high cost of the device, rise in the cost of the procedure associated with nuclear medicine and side effects associated with the use of nuclear medicine and low half-life of the radiopharmaceutical is expected to hamper the growth of global automated radiosynthesis market.
To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3095
Automated Radiosynthesis Modules Market: Region-wise Outlook
A geographic condition regarding automated radiosynthesis module market, it has been segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and the Middle East & Africa.
North America is expected to account for significant growth in automated radiosynthesis module market by revenue generation. Accelerated growth on development of new products and increased funding by governmental bodies for research and development in Western Europe proves the uplift of global automated radiosynthesis market. Rise in standards of health care services and increase in awareness towards the treatments in India and China is expected to favour the market for automated radiosynthesis modules in overall Asia Pacific region.
Automated Radiosynthesis Modules Market: Key Players
Examples of some of the market participants in the global automated radiosynthesis module market identified across the value chain include General Electric Company, Siemens Healthineers, IBA RadioPharma Solutions, Synthra GmbH, Eckert & Ziegler AG, Sumitomo Corp, Sofie Biosciences Inc., Trasis and Scintomics GmbH.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
Automated Radiosynthesis Modules Market: Segmentation
Automated Radiosynthesis Modules market is classified on the basis of end user and region
Based on End-User, the automated radiosynthesis modules market is segmented into the following:
- Hospitals
- Diagnostic Labs
- Radiology Clinics
- Ambulatory Surgical Centers
Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3095
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
